Lorraine J Gudas Selected Research

Retinoic Acid Receptors (Retinoic Acid Receptor)

3/2022	A retinoic acid receptor β2 agonist protects against alcohol liver disease and modulates hepatic expression of canonical retinoid metabolism genes.
1/2022	Synthetic Retinoids Beyond Cancer Therapy.
12/2021	A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
11/2021	A Retinoic Acid Receptor β 2 Agonist Improves Cardiac Function in a Heart Failure Model.
1/2019	Effects of AM80 compared to AC261066 in a high fat diet mouse model of liver disease.
10/2018	Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 Agonist.
10/2016	A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
6/2014	Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
4/2013	Inhibition of PRC2 histone methyltransferase activity increases TRAIL-mediated apoptosis sensitivity in human colon cancer cells.
1/2011	Retinoids, retinoic acid receptors, and cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorraine J Gudas Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 02/2002
18	Carcinogenesis 01/2020 - 03/2002
14	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 09/2002
9	Urinary Bladder Neoplasms (Bladder Cancer) 12/2013 - 05/2004
9	Carcinoma (Carcinomatosis) 07/2013 - 03/2002
7	Acute Promyelocytic Leukemia 01/2022 - 11/2007
6	Prostatic Neoplasms (Prostate Cancer) 11/2015 - 03/2002
5	Breast Neoplasms (Breast Cancer) 01/2011 - 11/2002
4	Liver Diseases (Liver Disease) 03/2022 - 01/2019
4	Alcoholism (Alcohol Abuse) 03/2022 - 11/2013
4	Kidney Neoplasms (Kidney Cancer) 01/2022 - 10/2003
4	Obesity 12/2021 - 01/2009
4	Squamous Cell Carcinoma of Head and Neck 01/2020 - 11/2013
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 01/2004
4	Teratocarcinoma 07/2010 - 03/2003
3	Leukemia 01/2022 - 04/2013
3	Adenocarcinoma 01/2022 - 03/2002
3	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2004
3	Non-alcoholic Fatty Liver Disease 12/2021 - 10/2016
3	Keratomalacia 01/2020 - 10/2010
3	Esophageal Squamous Cell Carcinoma 09/2015 - 06/2014
3	Lymphatic Metastasis 12/2013 - 12/2011
2	Fatty Liver 03/2022 - 12/2021
2	Fibrosis (Cirrhosis) 12/2021 - 11/2021
2	Hypoxia (Hypoxemia) 11/2021 - 01/2016
2	Heart Failure 11/2021 - 01/2018
2	Ischemia 11/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Wilms Tumor (Wilm's Tumor) 10/2018 - 02/2013
2	Mouth Neoplasms (Oral Cancer) 08/2015 - 10/2010
2	Vitamin A Deficiency 01/2015 - 12/2005
2	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 04/2013
2	Colonic Neoplasms (Colon Cancer) 06/2013 - 04/2013
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022

Drug/Important Bio-Agent (IBA)

27	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 02/2002
25	RetinoidsIBA 03/2022 - 02/2002
22	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2003
17	Vitamin A (Retinol)FDA LinkGeneric 03/2022 - 02/2002
12	Messenger RNA (mRNA)IBA 12/2021 - 05/2004
11	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 03/2022 - 06/2003
9	lecithin-retinol acyltransferaseIBA 11/2020 - 03/2002
7	CarcinogensIBA 09/2015 - 01/2004
6	Histone Deacetylase InhibitorsIBA 10/2020 - 03/2005
6	Transcription Factors (Transcription Factor)IBA 01/2019 - 11/2003
5	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
5	4- (4- (2- (n- butoxy)ethoxy)- 5- methylthiazol- 2- yl)- 2- fluorobenzoic acidIBA 12/2021 - 10/2016
5	AntibodiesIBA 06/2013 - 10/2003
5	Retinyl EstersIBA 03/2009 - 03/2002
4	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2003
4	Polycomb Repressive Complex 2IBA 12/2021 - 04/2013
4	Ethanol (Ethyl Alcohol)IBA 01/2021 - 03/2015
4	AndrogensIBA 11/2015 - 12/2011
4	Androgen Receptors (Androgen Receptor)IBA 11/2015 - 08/2004
4	Histones (Histone)IBA 08/2015 - 03/2005
4	DNA (Deoxyribonucleic Acid)IBA 01/2011 - 06/2003
4	ParaffinIBA 11/2009 - 10/2003
4	EnzymesIBA 11/2006 - 03/2002
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 03/2005
3	Small Interfering RNA (siRNA)IBA 01/2021 - 04/2013
3	LipidsIBA 01/2021 - 11/2011
3	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 08/2015 - 11/2013
3	Biomarkers (Surrogate Marker)IBA 08/2015 - 04/2005
3	Lysine (L-Lysine)FDA Link 10/2014 - 12/2011
3	Retinoid X Receptors (Retinoid X Receptor)IBA 06/2014 - 11/2003
3	Estrogen ReceptorsIBA 07/2013 - 11/2002
3	MethyltransferasesIBA 01/2011 - 03/2005
3	retinoic acid receptor betaIBA 12/2009 - 03/2004
3	Liposomes (Liposome)IBA 09/2007 - 09/2002
2	FenretinideIBA 01/2022 - 01/2021
2	AntioxidantsIBA 11/2021 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 11/2020 - 01/2004
2	Vorinostat FDA Link 10/2020 - 10/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 10/2008
2	Isotretinoin (Accutane)FDA LinkGeneric 10/2020 - 10/2003
2	Bexarotene (LGD1069)FDA Link 01/2019 - 06/2014
2	Cyclin D1IBA 12/2013 - 10/2010
2	Retinoic Acid 4-Hydroxylase (CYP26B1)IBA 10/2013 - 11/2007
2	Estrogens (Estrogen)FDA Link 07/2013 - 01/2011
2	Histone MethyltransferasesIBA 06/2013 - 04/2013
2	3-deazaneplanocinIBA 06/2013 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2013 - 06/2013
2	GlycogenIBA 05/2013 - 11/2011
2	retinol dehydrogenaseIBA 01/2012 - 02/2002
2	Bromodeoxyuridine (BrdU)IBA 10/2010 - 01/2004
2	Decitabine FDA Link 12/2009 - 03/2005
2	LecithinsIBA 11/2007 - 05/2004
2	Biological ProductsIBA 09/2007 - 10/2003
2	InterferonsIBA 09/2007 - 09/2002
1	CarbonIBA 01/2022
1	Arsenic Trioxide (Trisenox)FDA Link 01/2022
1	Mucin-2IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	IsotopesIBA 01/2022

Therapy/Procedure

19	Therapeutics 01/2022 - 09/2002
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
3	Cystectomy 07/2013 - 08/2004
2	Chemoprevention 01/2011 - 01/2004
1	Radiotherapy 01/2022